Singular Genomics News and Activities

Singular Genomics is owned by Deerfield.

They are in:

• Fund50%
• Biotechnology50%

Acquisition, funding and merger involving Deerfield.

• Deerfield has announced the acquisition of Singular Genomics  (posted on December 24 2024).

View the org chart displaying its 20 main executives

Most searched biographies at Singular Genomics

• John Stark, Chief Executive Officer
• Joshua Stahl, Independent Director
• Aaron Berlin, Chief Technology Officer

Popular executive movements at Singular Genomics

• John Stark has joined the company as Chief Executive Officer  (posted on April 29 2026).
• Joshua Stahl who was Chief Executive Officer and Director, becomes Independent Director  (posted on April 29 2026).

Popular executive movements at Deerfield

• Kurt Ehrig, Director of Technology, has left the company  (posted on February 24 2026).

Create your alert
to follow the executive moves at Singular Genomics.

Deerfield has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Singular Genomics

Social media about Singular Genomics

• Singular Genomics on Wikipedia, Google News & Yahoo Finance
• Singular Genomics on LinkedIn, X (Twitter) & YouTube